NIH-funded research R21 grant

RNF213 and Moyamoya Disease in Children

Official title: RNF213: Molecular Functions and Moyamoya Disease

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11356605 · Data updated 2026-11-12

A study in young children will explore how the RNF213 gene affects blood vessel cells and contributes to Moyamoya disease, with the aim of finding new ways to prevent or treat strokes.

More Moyamoya Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 9, 2026
Project endMay 30, 2028
Funding year2026
Award (this year)$429,000
NIH project number1R21NS149248-01
Project IDNIH-11356605 on NIH RePORTER

Who could benefit from this research

Could help

Children and young infants with or at risk for Moyamoya disease, especially those with RNF213-related variants.

Less likely to help

Children without Moyamoya or without RNF213 variants may not benefit from this specific genetic-focused approach.

What this research studies

This project focuses on Moyamoya disease, a condition where brain arteries narrow and can cause stroke in kids. Researchers will look at how a specific RNF213 variant seen in Asian families changes cell behavior, especially smooth muscle cells, and whether this leads to blocked vessels. They will connect laboratory findings to how the disease develops in very young patients and test strategies that may boost cell energy production to restore normal differentiation. The work builds on earlier findings that altering mitochondrial function can help prevent lesion formation in mouse models. The study combines genetic analysis with cell and animal experiments to map the steps from RNF213 mutation to vessel occlusion in early life.

Why it matters

Potential benefit: Understanding RNF213’s role could guide targeted therapies to prevent or slow Moyamoya in children.

How similar studies have gone: Prior work suggests RNF213 variants contribute to disease and mitochondrial pathways can influence vessel cell behavior, indicating a promising but continuing line of research.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Milewicz, Dianna M — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Milewicz, Dianna M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.